Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 122   

Articles published

GSK 1,667.00 +10.00 (0.60%)
price chart
Stock Seeing a Downward Gap Before the Open: GlaxoSmithKline plc (NYSE:GSK)
Shares of GlaxoSmithKline plc NYSE:GSK gapped down -0.11% between sessions as the shares stand at $43.88 before the open. A gap is a space between prices that occurs when the price of a stock makes a move down or up when there is no trading ...
Buy Signals Still Prevalent For GlaxoSmithKline plc (NYSE:GSK)
Wall Street analysts are holding on to a Buy rating on shares of GlaxoSmithKline plc (NYSE:GSK). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 2.00 on the ...
Key Stocks of the Day: GlaxoSmithKline plc (NYSE:GSK)
As it reflects the theoretical cost of buying the company's shares, the market cap of GlaxoSmithKline plc (NYSE:GSK) is currently rolling at 105411.61, making it one of the key stocks in today's market.
A look at a High Market Cap Stock: GlaxoSmithKline plc, GSK
GlaxoSmithKline plc, GSK is in the exchange NYSE and its industry is Drug Manufacturers - Major in the sector of Healthcare.
Update on GlaxoSmithKline plc (NYSE:GSK) for the day  Twin County News
Analyst's Checklist Stocks: Astrazeneca PLC (NYSE:AZN) , GlaxoSmithKline PLC ...
On 7/15/2016, shares of Astrazeneca PLC (NYSE:AZN) fell -0.33% in trading session and finally closed at $30.24. The company most recent volume stood at 7.35 million shares as compared to average volume of 4.7 million shares.
Analyst's Checklist Stocks: GlaxoSmithKline PLC (NYSE:GSK) , Supernus ...
GlaxoSmithKline PLC (NYSE:GSK) accumulated +0.71%, closing at $44.23 after floating between $43.96 and $44.31. The company has market capitalization of $107.43B.
GlaxoSmithKline PLC (LON:GSK) Issued With 'Neutral' Rating At Exane BNP Paribas
On Friday Exane BNP Paribas reiterated its target for shares of GlaxoSmithKline PLC as 'Neutral' recommending a target price of 1430 for investors; potentially meaning there is a decrease of -10.46% from GlaxoSmithKline PLC's share price of 1597.
Shares Of GlaxoSmithKline PLC (LON:GSK) Rated As Neutral By Analysts At ...  Fiscal Standard
Exane BNP Paribas issued a report on (LON:GSK) GlaxoSmithKline PLC, renewing ...  Breaking Finance News
GlaxoSmithKline PLC (NYSE:GSK) Has Been Assigned An ABR Of 2.2
GlaxoSmithKline PLC (NYSE:GSK) stock has bullish outlook. Based on the survey data released by the Zacks as of 2016-07-24, the stock of GlaxoSmithKline PLC (NYSE:GSK) has been assigned an ABR of 2.2 rating. The ABR of one is a signal to go ahead ...
What analysts set expectations about Earnings? GlaxoSmithKline PLC (NYSE:GSK ...
Shares of GlaxoSmithKline PLC (NYSE:GSK) closed the trading at a price of $44.23 with the positive change of +0.71%. In the past session approximately 3.35 million shares were exchanged against the average daily trading volume of 3.49 million shares.
Quick Look Sell-side Earnings Watch: MetLife, Inc. (NYSE:MET), GlaxoSmithKline ...
Analysts are projecting that GlaxoSmithKline PLC (NYSE:GSK) will report EPS of $0.54 when they next file their quarterly earnings.